SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,816,477 | -74.7% | 517,636 | -77.0% | 0.02% | -73.2% |
| Q2 2023 | $433,753,453 | -68.6% | 2,253,733 | -67.0% | 0.08% | -70.1% |
| Q1 2023 | $1,382,761,373 | +8.9% | 6,829,463 | -30.9% | 0.27% | +7.5% |
| Q4 2022 | $1,269,844,836 | -5.7% | 9,881,292 | +0.4% | 0.26% | -11.1% |
| Q3 2022 | $1,346,687,000 | -12.8% | 9,842,049 | +12.8% | 0.29% | -7.7% |
| Q2 2022 | $1,543,735,000 | -14.1% | 8,724,621 | -30.1% | 0.31% | +1.0% |
| Q1 2022 | $1,797,170,000 | -0.1% | 12,476,025 | +7.2% | 0.31% | +6.9% |
| Q4 2021 | $1,799,071,000 | -13.1% | 11,636,937 | -4.5% | 0.29% | -18.2% |
| Q3 2021 | $2,070,113,000 | +24.5% | 12,191,481 | +15.8% | 0.35% | +27.1% |
| Q2 2021 | $1,662,111,000 | +41.5% | 10,527,684 | +24.5% | 0.28% | +33.8% |
| Q1 2021 | $1,174,430,000 | +18.4% | 8,457,643 | +49.4% | 0.21% | +13.1% |
| Q4 2020 | $991,669,000 | – | 5,662,148 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |